Literature DB >> 15027318

[Minimally invasive therapy under image guidance--emphasizing MRI-guided cryotherapy].

Junta Harada1, Takuji Mogami.   

Abstract

Cryotherapy may provide a method for the focal destruction of cancerous tissue while preserving most of the surrounding normal tissue. The mechanisms of tissue injury in cryotherapy are 1) intracellular ice formation, 2) dehydration of cells, and 3) stagnation of microcirculation. MR images were superior to CT and ultrasound in monitoring interstitial cryotherapy, because the very short T2 relaxation time of ice affords excellent contrast between the ice and surrounding tissue, allowing an accurate depiction of the entire extent of the iceball. MR imaging demonstrates the iceball as sharply marginated regions of signal loss that expanded and engulfed the renal and hepatic masses with clear contrast between the iceball and surrounding tissue. Recently, a fast Joule-Thomson cryocycling device for MR-compatible cryotherapy application was developed and clinical trials under MRI-guided monitoring were performed in several sites of the body. In our series, cryotherapy was performed in 14 cases of renal tumor and 4 cases of hepatic malignancy under the guidance of a horizontal open MR system. Fourteen of the 18 cases were discharged a day after cryotherapy. One of the residual tumors at the margin of a renal cancer required re-cryoablation. All cryoablated tumors resolved and there were no serious complications and no clinically significant changes-during the follow-up study.

Entities:  

Mesh:

Year:  2004        PMID: 15027318

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  1 in total

1.  Modeling Cryotherapy Ice Ball Dimensions and Isotherms in a Novel Gel-based Model to Determine Optimal Cryo-needle Configurations and Settings for Potential Use in Clinical Practice.

Authors:  Taimur T Shah; Uri Arbel; Sonja Foss; Andrew Zachman; Simon Rodney; Hashim U Ahmed; Manit Arya
Journal:  Urology       Date:  2016-02-20       Impact factor: 2.649

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.